| UniProt ID | AL3B1_HUMAN | |
|---|---|---|
| UniProt AC | P43353 | |
| Protein Name | Aldehyde dehydrogenase family 3 member B1 | |
| Gene Name | ALDH3B1 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 468 | |
| Subcellular Localization |
Cell membrane Lipid-anchor . Primarily in the plasma membrane as well as in some punctate structures in the cytoplasm. |
|
| Protein Description | Oxidizes medium and long chain saturated and unsaturated aldehydes. Metabolizes also benzaldehyde. Low activity towards acetaldehyde and 3,4-dihydroxyphenylacetaldehyde. May not metabolize short chain aldehydes. May use both NADP(+) and NAD(+) as cofactors. May have a protective role against the cytotoxicity induced by lipid peroxidation.. | |
| Protein Sequence | MDPLGDTLRRLREAFHAGRTRPAEFRAAQLQGLGRFLQENKQLLHDALAQDLHKSAFESEVSEVAISQGEVTLALRNLRAWMKDERVPKNLATQLDSAFIRKEPFGLVLIIAPWNYPLNLTLVPLVGALAAGNCVVLKPSEISKNVEKILAEVLPQYVDQSCFAVVLGGPQETGQLLEHRFDYIFFTGSPRVGKIVMTAAAKHLTPVTLELGGKNPCYVDDNCDPQTVANRVAWFRYFNAGQTCVAPDYVLCSPEMQERLLPALQSTITRFYGDDPQSSPNLGRIINQKQFQRLRALLGCGRVAIGGQSDESDRYIAPTVLVDVQEMEPVMQEEIFGPILPIVNVQSLDEAIEFINRREKPLALYAFSNSSQVVKRVLTQTSSGGFCGNDGFMHMTLASLPFGGVGASGMGRYHGKFSFDTFSHHRACLLRSPGMEKLNALRYPPQSPRRLRMLLVAMEAQGCSCTLL | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 1 | Acetylation | -------MDPLGDTL -------CCCHHHHH | 12.35 | 22814378 | |
| 41 | Ubiquitination | GRFLQENKQLLHDAL HHHHHHHHHHHHHHH | 41.38 | 21890473 | |
| 41 (in isoform 1) | Ubiquitination | - | 41.38 | 21890473 | |
| 41 | Ubiquitination | GRFLQENKQLLHDAL HHHHHHHHHHHHHHH | 41.38 | 21890473 | |
| 41 (in isoform 2) | Ubiquitination | - | 41.38 | 21890473 | |
| 89 | Ubiquitination | MKDERVPKNLATQLD HCCCCCCCCHHHHHH | 62.83 | 21890473 | |
| 89 (in isoform 1) | Ubiquitination | - | 62.83 | 21890473 | |
| 89 | Ubiquitination | MKDERVPKNLATQLD HCCCCCCCCHHHHHH | 62.83 | 21890473 | |
| 93 | Phosphorylation | RVPKNLATQLDSAFI CCCCCHHHHHHHHHH | 32.60 | 30631047 | |
| 97 | Phosphorylation | NLATQLDSAFIRKEP CHHHHHHHHHHCCCC | 33.40 | 30631047 | |
| 183 | Phosphorylation | LLEHRFDYIFFTGSP HHHEECCEEEEECCC | 9.27 | 68707961 | |
| 187 | Phosphorylation | RFDYIFFTGSPRVGK ECCEEEEECCCCHHH | 26.46 | 68707967 | |
| 189 | Phosphorylation | DYIFFTGSPRVGKIV CEEEEECCCCHHHHH | 13.38 | 68707973 | |
| 202 | Ubiquitination | IVMTAAAKHLTPVTL HHHHHHHHHCCCEEE | 34.13 | - | |
| 205 | Phosphorylation | TAAAKHLTPVTLELG HHHHHHCCCEEEEEC | 18.55 | 46162035 | |
| 208 | Phosphorylation | AKHLTPVTLELGGKN HHHCCCEEEEECCCC | 18.73 | - | |
| 214 | Ubiquitination | VTLELGGKNPCYVDD EEEEECCCCCEECCC | 56.79 | - | |
| 252 (in isoform 2) | Ubiquitination | - | 4.56 | 21890473 | |
| 279 | Phosphorylation | YGDDPQSSPNLGRII HCCCCCCCCCHHHHC | 16.74 | 21815630 | |
| 289 (in isoform 1) | Ubiquitination | - | 48.90 | 21890473 | |
| 289 | Ubiquitination | LGRIINQKQFQRLRA HHHHCCHHHHHHHHH | 48.90 | - | |
| 323 (in isoform 2) | Ubiquitination | - | 32.02 | 21890473 | |
| 338 (in isoform 2) | Ubiquitination | - | 17.75 | 21890473 | |
| 360 | Ubiquitination | EFINRREKPLALYAF HHHHHCCCCEEEEEE | 43.45 | 21906983 | |
| 360 (in isoform 1) | Ubiquitination | - | 43.45 | 21890473 | |
| 368 | Phosphorylation | PLALYAFSNSSQVVK CEEEEEECCCHHHHH | 27.86 | 18187866 | |
| 375 | Ubiquitination | SNSSQVVKRVLTQTS CCCHHHHHHHHHCCC | 37.62 | 21890473 | |
| 375 | Ubiquitination | SNSSQVVKRVLTQTS CCCHHHHHHHHHCCC | 37.62 | 21890473 | |
| 375 (in isoform 1) | Ubiquitination | - | 37.62 | 21890473 | |
| 400 (in isoform 2) | Ubiquitination | - | 3.20 | 21890473 | |
| 432 | Phosphorylation | HRACLLRSPGMEKLN CCCHHHCCCCHHHHH | 26.27 | 30576142 | |
| 437 | Ubiquitination | LRSPGMEKLNALRYP HCCCCHHHHHHCCCC | 37.84 | 21890473 | |
| 437 (in isoform 1) | Ubiquitination | - | 37.84 | 21890473 | |
| 437 | Ubiquitination | LRSPGMEKLNALRYP HCCCCHHHHHHCCCC | 37.84 | 21890473 | |
| 443 | Phosphorylation | EKLNALRYPPQSPRR HHHHHCCCCCCCHHH | 21.80 | 30576142 | |
| 447 | Phosphorylation | ALRYPPQSPRRLRML HCCCCCCCHHHHHHH | 26.58 | 30576142 | |
| 463 | S-palmitoylation | VAMEAQGCSCTLL-- HHHHHCCCCEEEC-- | 1.69 | 23721920 | |
| 464 | Phosphorylation | AMEAQGCSCTLL--- HHHHCCCCEEEC--- | 19.57 | 50564585 | |
| 465 | Geranylgeranylation | MEAQGCSCTLL---- HHHCCCCEEEC---- | 3.46 | 23721920 | |
| 465 | Methylation | MEAQGCSCTLL---- HHHCCCCEEEC---- | 3.46 | - | |
| 465 | Geranylgeranylation | MEAQGCSCTLL---- HHHCCCCEEEC---- | 3.46 | 23721920 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of AL3B1_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of AL3B1_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of AL3B1_HUMAN !! | ||||||
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Phosphorylation | |
| Reference | PubMed |
| "Automated phosphoproteome analysis for cultured cancer cells by two-dimensional nanoLC-MS using a calcined titania/C18 biphasic column."; Imami K., Sugiyama N., Kyono Y., Tomita M., Ishihama Y.; Anal. Sci. 24:161-166(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-368, AND MASSSPECTROMETRY. | |